SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-22-003341
Filing Date
2022-03-24
Accepted
2022-03-24 18:25:58
Documents
1
Period of Report
2022-03-15

Document Format Files

Seq Description Document Type Size
1 form3-03242022_030345.html 3  
1 form3-03242022_030345.xml 3 3948
  Complete submission text file 0001415889-22-003341.txt   5451
Mailing Address C/O CONTINENTAL BUILDING PRODUCTS 12950 WORLDGATE DRIVE HERNDON VA 20170
Business Address
Strassberg Ira S (Reporting) CIK: 0001699729 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38302 | Film No.: 22767811

Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Issuer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations